J 2020

Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma

GRIGOLETTO, V.; A. TAGARELLI; M. SPARBER-SAUER; E. KOSCIELNIAK; D. ORBACH et al.

Základní údaje

Originální název

Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma

Autoři

GRIGOLETTO, V.; A. TAGARELLI; M. SPARBER-SAUER; E. KOSCIELNIAK; D. ORBACH; M. DUPLAN; T. STACHOWICZ-STENCEL; E. BIEN; R. LOPEZ-ALMARAZ; T. BEN-AMI; A. POURTSIDIS; G. OSTERLUNDH; Pavel MAZÁNEK; J. ZSIROS; N. FARINHA; A. FERRARI a G. BISOGNO

Vydání

European journal of pediatrics, New York, Springer, 2020, 0340-6199

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30209 Paediatrics

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.183

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00115983

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Childhood cancer; Rare tumors; Pleuropulmonary blastoma; Cancer registry

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 31. 8. 2020 12:13, Mgr. Tereza Miškechová

Anotace

V originále

Very rare tumors (VRTs) account for up to 11% of childhood cancers. Dedicated national groups and registries only exist in some European countries. Pleuropulmonary blastoma (PPB) is a very rare intrathoracic pediatric tumor with a potentially severe prognosis. Due to its rarity, it sometimes goes unrecognized. We investigated PPB diagnostic capability and possible correlations between diagnostic performance and VRT-dedicated activities. The number of cases of PPB registered between 2000 and 2014 at pediatric oncology centers in Europe was compared with the number of expected cases. Data sources included VRT registries, population-based cancer registries, and hospital registries. Data were obtained for 25 countries, grouped into 4 geographical regions. The expected cases were 111, and the observed cases were 129. The observed-to-expected ratio was 1.86 for Northern Europe, 1.33 for Southern Europe, 1.22 for Central Europe, and 0.65 for Eastern Europe. More cases than expected were registered in all countries with an official VRT registry. Conclusion: The number of cases observed is consistent with expectations, but disparities exist across Europe. Difficulties in diagnosing PPB emerged in most Eastern countries. The incidence rate of PPB may be underestimated. The creation of VRT-dedicated groups and a European Registry for VRTs could help to reduce inequalities.